(Finance) – “2021 was still a difficult yearwhich obviously started a lot uphill and then we were good at maintaining the pace we took from the beginning, which has seen a lot of innovation and therefore unfortunately sometimes even low margins, but we have kept customers “. Telebag Walter Bertin, founder and CEO Of Labomaron the sidelines of the Investor Conference “Mid & Small in London 2022”, organized by Virgilio IR e Mediobanca. “In our world, the historical products are winter products and all probiotics: for us this means 25% of the turnover and they have dramatically reduced because the pathology disappeared with the use of the mask. We have integrated with new products and have kept more or less the size. Now the old products are returning, so we have these and those “, added the number one of the company listed on Euronext Growth Milan and active in the development and production of food supplements and medical devices.
In recent months, the company has also completed two extraordinary transactions. “We brought home 100% of a company that is highly strategic in November, because I founded it in 2011 together with a colleague and finally took it home because it is all the part of research and development on raw materials: starting from plants, which is my passion anyway, and transforming them into something that we can use in products and give to my customers “, explained Bertin.” On the other hand, we did something different: we took 70% of a company based in Orvieto, with a very good and very energetic businesswoman who works normally in hospitals with products that are used for bedridden patients who have skin problems: so we see opportunities in the post-surgery patient, where there will be a future because we are all destined to age “.
“The focus now is to consolidate what we have taken, because in any case we have taken small-medium sized companies, all with very strong energy within and this synergy is now being realized – the CEO of Labomar pointed out – But to put everyone in agreement and make a common project in this synergy also the supply chain is not easy and we want to complete it. So we can to ground the value of what we have acquired“.
“On the other hand, we are not stopping in scouting – he continued – Where I will certainly try to do something is the technological field: I find beautiful companies, structures and startups that have important technologies and perhaps not yet expressed in my field. I would like to collect this and support these companies, giving them the opportunity to grow. Mine will be mainly on the technological side “.
They look at the outlook for the current fiscal year, he said: “The 2022 is complicated because of the problems everyone has. For raw materials with high prices, and which you cannot find, we are trying to do something, but it is not easy. Furthermore, we are still very affected by Covid and positivity, as we lose some work shifts because people are positive. Finally, we are not insensitive to what is causing the conflict, either because we are people anyway and we absolutely agree that these things must not happen, both on the raw materials and market fronts, because we anyway especially in Russia we have a market, in Ukraine also, and we cannot use it for safety“.
“We see 2022 in good growth, because in any case the market is moving – concluded Bertin – We work with the doctor’s prescription, and the doctor prescribes today, we work with the pharmacy, and today the pharmacy has people who go. So I see it as good from a dimensional point of view and I hope to be able to exercise everything we have available “.